KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Community Healthcare Trust (CHCT) Depreciation & Amortization (CF) (2016 - 2025)

Community Healthcare Trust (CHCT) has disclosed Depreciation & Amortization (CF) for 11 consecutive years, with $10.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (CF) changed 0.19% year-over-year to $10.8 million, compared with a TTM value of $43.5 million through Dec 2025, up 1.69%, and an annual FY2025 reading of $43.5 million, up 1.69% over the prior year.
  • Depreciation & Amortization (CF) was $10.8 million for Q4 2025 at Community Healthcare Trust, down from $10.9 million in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $11.2 million in Q3 2023 and bottomed at $7.2 million in Q1 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $9.4 million, with a median of $9.7 million recorded in 2023.
  • The sharpest move saw Depreciation & Amortization (CF) skyrocketed 40.05% in 2023, then dropped 2.51% in 2024.
  • Year by year, Depreciation & Amortization (CF) stood at $7.8 million in 2021, then rose by 6.29% to $8.3 million in 2022, then grew by 23.22% to $10.2 million in 2023, then rose by 5.36% to $10.8 million in 2024, then decreased by 0.19% to $10.8 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for CHCT at $10.8 million in Q4 2025, $10.9 million in Q3 2025, and $10.9 million in Q2 2025.